ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.49
-0.01 (-0.40%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +855.0% upside
Low Target $21.93
Average Target $23.78
High Target $37.21
Current Price $2.49
Current
$2.49
Target
$23.78
$21.93 $23.78 avg $37.21
Scenario Analysis
Bear Case
$21.93
780.7%
Low target
Base Case
$23.78
+855.0%
Avg target
Bull Case
$37.21
+1,394.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.00
-37.8% from high
52-Week Low
$1.65
+50.9% from low
Target vs 52W High
$23.78
+494.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%